课题基金 / 基金详情

CONTROL OF FIBRIN TURNOVER IN PLEURAL DISEASE

CONTROL OF FIBRIN TURNOVER IN PLEURAL DISEASE
胸膜疾病中纤维蛋白周转的控制
批准号:
6125902
负责人:
Steven Idell
金额:
$13.01万
依托单位国家:
美国
项目类别:
财政年份:
1991
资助国家:
美国
项目状态:
已结题
起止时间:
1991-09-01 至 2000-08-31

项目摘要

项目成果

Steven Idell的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Clinical and experimental observations indicate that extravascular fibrin deposition is important in the pathogenesis of pleural organization. However, little is known about the control of local fibrin turnover during evolving acute pleural injury and fibrotic repair. We will use an established rabbit model of pleural injury to identify in vivo mechanisms of fibrin formation and fibrinolysis and-to establish the contribution of the mesothelium to the process. Complementary in vitro experiments will be used to define pathways of fibrin turnover by which mesothelial cells influence remodeling via the control of coagulation and regulation of proteolysis by urokinase and its receptor (uPAR). We will also determine the effect of uPAR on mesothelial cell functions including proliferation and migration and elucidate mechanisms which regulate uPAR expression. We will use a variety of protein chemistry, molecular biology and immunohistologic techniques to address these aims. Organization of the pleural compartment after injury leads to local scarring, with morbidity related to both restricted lung function and invasive therapeutic procedures. Our hypothesis is that pleural organization and scarring can be prevented selectively interfering with local fibrin formation and/or clearance. Our studies will define the role of these pathways in pleural organization and could provide novel clinical strategies to preempt or limit the process.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Myocardin in the pathogenesis of pleural remodeling
Myocardin in the pathogenesis of pleural remodeling
PAI-1 Targeted Intrapleural Fibronolytic Therapy
PAI-1 Targeted Intrapleural Fibronolytic Therapy
海外基金